EP0335955A1 - Method for culturing pearls - Google Patents
Method for culturing pearlsInfo
- Publication number
- EP0335955A1 EP0335955A1 EP88909428A EP88909428A EP0335955A1 EP 0335955 A1 EP0335955 A1 EP 0335955A1 EP 88909428 A EP88909428 A EP 88909428A EP 88909428 A EP88909428 A EP 88909428A EP 0335955 A1 EP0335955 A1 EP 0335955A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- medium
- source
- nucleus
- nacre
- mollusca
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 26
- 239000011049 pearl Substances 0.000 title abstract description 41
- 238000012258 culturing Methods 0.000 title description 6
- 241000237852 Mollusca Species 0.000 claims abstract description 32
- 150000001413 amino acids Chemical class 0.000 claims abstract description 32
- 150000003839 salts Chemical class 0.000 claims abstract description 19
- 239000011248 coating agent Substances 0.000 claims abstract description 5
- 238000000576 coating method Methods 0.000 claims abstract description 5
- 150000003431 steroids Chemical class 0.000 claims abstract 2
- 239000002609 medium Substances 0.000 claims description 43
- 239000001963 growth medium Substances 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 14
- 235000015097 nutrients Nutrition 0.000 claims description 12
- 230000002710 gonadal effect Effects 0.000 claims description 10
- 230000012010 growth Effects 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 8
- 241000490567 Pinctada Species 0.000 claims description 7
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 241000237858 Gastropoda Species 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 230000001605 fetal effect Effects 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 241000217381 Anodonta Species 0.000 claims description 2
- 241000548230 Crassostrea angulata Species 0.000 claims description 2
- 241000382825 Cristaria plicata Species 0.000 claims description 2
- 241000545767 Elliptio complanata Species 0.000 claims description 2
- 241000237876 Haliotis corrugata Species 0.000 claims description 2
- 241000237880 Haliotis cracherodii Species 0.000 claims description 2
- 241000143510 Haliotis discus hannai Species 0.000 claims description 2
- 241000237878 Haliotis fulgens Species 0.000 claims description 2
- 241001522824 Haliotis gigantea Species 0.000 claims description 2
- 241000385245 Ligumia nasuta Species 0.000 claims description 2
- 241001212699 Pinctada martensii Species 0.000 claims description 2
- 241001490476 Pinctada maxima Species 0.000 claims description 2
- 241001463804 Pteria macroptera Species 0.000 claims description 2
- 244000184734 Pyrus japonica Species 0.000 claims description 2
- 241001655269 Strophitus undulatus Species 0.000 claims description 2
- 241001600163 Tridacna gigas Species 0.000 claims description 2
- 241000545760 Unio Species 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 239000012266 salt solution Substances 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 10
- 239000000758 substrate Substances 0.000 abstract description 6
- 239000000654 additive Substances 0.000 abstract description 3
- 238000011534 incubation Methods 0.000 abstract description 2
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 53
- 229940024606 amino acid Drugs 0.000 description 24
- 235000001014 amino acid Nutrition 0.000 description 24
- 235000002639 sodium chloride Nutrition 0.000 description 17
- 239000000284 extract Substances 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 239000005556 hormone Substances 0.000 description 7
- 229940088597 hormone Drugs 0.000 description 7
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 5
- 239000003098 androgen Substances 0.000 description 5
- 230000001857 anti-mycotic effect Effects 0.000 description 5
- 239000002543 antimycotic Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000010984 cultured pearl Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 241000237502 Ostreidae Species 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229960003767 alanine Drugs 0.000 description 4
- 229960005261 aspartic acid Drugs 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 229960003136 leucine Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229960004452 methionine Drugs 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 235000020636 oyster Nutrition 0.000 description 4
- 229960005190 phenylalanine Drugs 0.000 description 4
- 229960001153 serine Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 108010009736 Protein Hydrolysates Proteins 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 229960003121 arginine Drugs 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000002149 gonad Anatomy 0.000 description 3
- 229960002885 histidine Drugs 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 235000004400 serine Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 101000856746 Bos taurus Cytochrome c oxidase subunit 7A1, mitochondrial Proteins 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000237890 Haliotis Species 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000936964 Isognomon Species 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 230000010800 Physiochemical Activity Effects 0.000 description 1
- 241000490568 Pinctada fucata Species 0.000 description 1
- 241001463913 Pinna Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000879903 Pteria Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/74—Undefined extracts from fungi, e.g. yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/10—Mineral substrates
- C12N2533/18—Calcium salts, e.g. apatite, Mineral components from bones, teeth, shells
Definitions
- the subject invention concerns coating of nucleating agents with nacre i_n vitro using mantle tisssue from mollusca.
- This invention relates to a methods and compositions of matter utilized therein, for culturing pearls, and in particular to a method of producing pearls by using an in vitro cell culture system to maintain biological and physiochemical activities of the mantle tissues found in pearl forming mollusks and gastropods.
- a pearl is a gem most commonly formed by bivalve mollusks, particularly by several marine species known as pearl oysters. Pearls are formed as a protection against the irritation caused by foreign objects, generally parasites, grains of sand, or bits of gravel, which lodge inside the shell. A fold of soft tissue envelopes the foreign particle and deposits layer after layer of nacre on it, similar to the mother-of-pearl lining the shell. Any shelled mollusk or gastropod is theoretically capable of producing a pearl, but most pearls exhibiting gem quality are produced by a specific genus of pinctada, haliotis, and certain freshwater bivalves.
- Cultured pearls are generally produced by manually implanting a nucleus with small pieces of mantle tissue in an oyster for approximately two to three years.
- the present invention circumvents the use of live oysters for culturing pearls. It is a process based on a cell culture system specifically designed and developed to provide sustenance and nourishment to pearl forming tissues kept in vitro. The process involves sustaining the viability of mantle tissue explants by providing necessary chemical and physical components in a culture medium.
- the composition of the medium to maintain and grow tissues includes a combination of nutrients associated with the naturally available medium in which the tissue grows, which medium may include inorganic salts, a source of amino acids, a sugar source, naturally occurring proteins, etc.
- mantle tissue when mantle tissue is extracted from a mollusk and maintained under certain _in vitro conditions, the tissue has physiological characteristics and functions duplicating those in normal biological conditions.
- the present invention uses complex growth media with the appropriate chemical and physical components necessary to simulate the ideal conditions in vitro for mantle tissues.
- the chemical and ultrastructural properties of the pearls produced by this invention are substantially identical to the naturally occurring or cultured pearls currently on the market, as has been demonstrated by a series of electron micrographs comparing the ultrastructure and chemical properties of conventionally cultured pearls with those of the pearls produced by the present invention. From transmission electron micrographs illustrating the surface structure of a conventionally produced cultured pearl presently found on the market and a pearl produced from the present invention, it could be seen that crystal size and shape of the nacre as well as general surface topography are substantially identical between the two pearls. Chemical identifications using X-ray diffraction of a conventionally produced cultured pearl and a pearl produced by the present invention showed that calcium carbonate (aragonite) is the predominate phase found in both pearls.
- the culture media used in the process of this invention are complex growth media.
- the media employed may take many forms, normally providing an environment which to varying degrees approaches the natural fluids, cellular or extracellular.
- the medium will include inorganic salts, a source of amino acids, a source of metabolic energy, normally a metabolizable or assimilable saccharide source, and desirably a source of hormones.
- the various components of the nutrient medium which may be involved may be separated generally into the following components: (i) inorganic salts, (ii) amino acids, (iii) vitamins, (iv) naturally occurring protein containing compositions, (v) antibiotics and antimycotics, (vi) assimilable energy source and (vii) C0 2 , CO3 and/or 0 2 .
- the nutrient medium will have the inorganic salts necessary for growth of the tissue, approximating the natural medium.
- various other factors may be included, where some factors may be provided by the presence of other factors.
- the naturally occurring material may include the factors which are otherwise added to a synthetic medium.
- the naturally occurring material may serve as an alternative to another component. Therefore, there may be wide variation in the media which are employed, and a number of different media may be employed, each with different degrees of success in the rapidity with which the pearls are obtained.
- the tissue when using mollusk tissue as a component of the medium, the tissue may serve as a source of amino acids and hormones. Protein hydrolysates may serve as a source of amino acids, so that individual amino acids may not be included.
- Conditioned medium from the growth of mantle tissue may be employed, where the conditioned medium may be replenished to previous levels of certain components such as an energy source and undesirable factors reduced to a desirable level.
- the basic medium will have a salt medium approximating the natural medium of the tissue at an appropriate pH, a source of assimilable energy, a source of essential amino acids, and additional factors which promote growth.
- factors may include mollusca tissue, particularly the gonadal tissue components, which may also serve as the source of amino acids, fetal serum, a steriod source such as an androgen extract, yeast extract or the like.
- the inorganic salts in the growth medium will usually contain all of the ions that are found in the mollusk mantle tissues themselves during their biological activities. In order to determine the chemical nature of the fluid surrounding the mantle tissue, the ionic concentrations of such fluid were investigated and determined. In Table I, the average concentrations of inorganic elements found are shown.
- compositions of inorganic salts were formulated for use in the complex growth medium as found in Table II below.
- salt media proposed above are convenient, but other salt media may be formulated which would provide the desired ionic composition and normalities of the essential ions.
- L-valine Of particular interest as a source of individual amino acids are the amino acids serine, alanine, arginine, aspartic acid, glycine, histidine, leucine, methionine, and phenylalanine.
- amino acids it is understood that the naturally occurring L-stereoisomer is intended.
- protein hydrolysates or extracts may be employed, by themselves or in conjunction with individual amino acids, where the protein hydrolysates or extracts may provide for a more economical source of amino acids.
- Vitamins are optional. If included, the vitamins present in the complex growth medium are similar to those used for other cell and tissue cultures with some variations in concentration. Specific vitamins and concentrations are shown in Table V below. None some or all may actually be used in the complex growth medium.
- Vitamin A (acetate)
- the hormones found associated at or near the activities of the mantle tissues were determined and may be classified as corticosteroids, androgens or modified versions of estrogen. These hormonal components or metabolic intermediates were added to the medium to facilitate biosynthesis of these hormones.
- Androgen extract may be obtained from commercial sources and may be used in amounts varying from 0.005 to 0.2 mg/L. It has been observed that a growth medium containing serum extracts from the reproductive organs of the same mollusk was observed to yield the most success in proliferating the growth of the mantle tissues. The serum extracts were found to provide the levels of hormones necessary to sustain mantle tissue growth. Without the presence of this reproductive organ serum, however, the hormone additives, although not essential in maintaining tissue culture, were found to be desirable in enhancing tissue growth.
- tissue from the mantle explant source or other related species particularly comprising gonadal tissue or lyophilized gonadal tissue.
- the tissue may be minced or ground either before or after lyophilization to provide the tissue in easily dispersible form, e.g. a powder.
- the tissue when employed will be composed of cells, fragments of the cells and other materials present in the tissue when removed from the source.
- the "lyophilized tissue may be dispersed in the nutrient medium under mild conditions with agitation, and may be incorporated in biocompatible gels, such as agar or collagen gels.
- the amount of the lyophilized tissue may be varied widely and may be optimized in accordance with the other components of the nutrient medium. Beneficial results may be obtained by using a ratio of from about 0.1 to 2 of the volume of the tissue prior to lyophilization to the volume of medium.
- Antibiotics and anti ycotics such as penicillin and streptomycin may also be used during tissue extraction procedures and may also be used to control contamination levels during mantle tissue culture.
- the antibiotics and antimycotics used in the complex growth medium are listed below in Table VI.
- Saccharide sources include glucose, galactose, glycogen, sucrose, etc.
- lactalbumin hydrolysate provided significant benefits in the absence of other protein sources.
- the system is buffered to provide a physiologically acceptable pH.
- Sodium bicarbonate (inorganic salt) and phenol red were added to control and monitor the pH of the solution.
- the preferred pH range is 7.2 to 7.9.
- a pH as low as 6.5 and as high as 9.3 have been observed to sustain viability of the mantle tissues.
- Carbon dioxide enriched air or a carbonated source was added to the growth medium to keep the pH of the medium within the overall range of 6.6 to 8.9.
- Vitamin A (acetate)
- Formulations were prepared for growth media using distilled water containing the salt composition of Medium A or sea water and gonad organ extracts, where the gonad organ extracts were obtained by isolating the gonads from the body mass of the mollusc, lyophilizing the gonadal tissue and grinding the tissue to form a powder. The powder was then uniformly dispersed in the water by stirring. The amount of gonadal tissue was based on the original volume of the tissue and was in a volume ratio to water of 0.25 to 1. Other formulations combined the above formulation or used androgen extract (Sigma) in place of the gonadal tissue. The androgen extract ranged in the amount of 0.01 to O.lmg/L.
- a portion or all of a mantle tissue is explanted from a mollusk or gastropod which belong to genus thereof which produce mother-of-pearl material in their shells, such as the genera Pinctada, Isognomon, Pteria, Pinna, Haliotis, Atrima, etc., e.g., Pinctada martensii, Pinctada margritifera, Pinctada maxima, Pinctada fucata, Pteria macroptera, Atrima japonica, Ostrea gigas, Unio margritifera, Cristaria plicata, Tridacna gigas, Haliotis gigantea, ⁇ ypriopsis schlegeli, Haliotis fulgens, Haliotis corrugata, Haliotis cracherodii, Haliotis discus hannai, Ligumia n
- the pieces of the mantle tissue fragments are optionally washed in seawater containing antibiotics and/or antimycotics, e.g., 100 Units penicillin G (sodium salt)/ml and 100 ug/ml streptomycin.
- the seawater may be prepared in the laboratory and would consist generally of water with inorganic salts in concentrations thereof as indicated in Table II above.
- the tissue part(s) or intact mantle tissue(s) are transferred into a carbon dioxide or oxygen enriched complex growth medium comprised of inorganic salts, amino acids, vitamins and growth factors, hormones, antibiotics and antimycotics, animal serum extracts and glucose.
- Biocompatible material such as glass, porcelain, old shells containing calcite and/or the aragonite phase(s) of calcium carbonate, and/or calcium phosphates in the form of spheres or hemispheres are introduced into the medium for nacre deposition.
- the material which serves as a nucleating substrate may be of any shape, normally being round or ellipsoid for pearl formation.
- the smallest dimension of the material which serves as the substrate will be usually at least about 1mm, usually at least about 2mm and may be as large as 20mm or larger.
- the substrate will usually have a diameter from about 2 to 15, usually 7 to 10mm.
- small, i.e., less than 1 m ⁇ r pieces of mantle tissue were sectioned and removed from a pearl forming adult mollusk. Each piece was washed in saltwater containing the inorganic salt components described above and placed in pre-sterilized culture dishes. Sterilized complex growth medium, filtered through a 0.22 ⁇ m millipore filter (Millipore Corp., Bedford, MA 01730) was immediately added to each dish containing the tissue fragments. Small nuclei, i.e., glass beads or spheres made from clam shells, were then placed in each dish and positioned so that maximal physical contact was made with the tissue.
- the medium is changed every two days or when the medium pH rises above 7.8, whichever occurs sooner and depending on tissue mass to medium content ratio.
- Precise measurement of pH may be done with a pH measuring apparatus. After the pearl reached its desired quality and/or size, it was removed from the dish and the attached tissue removed. The removed tissue was dissected and fragments thereof used again in the production of additional pearls.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Farming Of Fish And Shellfish (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Nacre coating of a biocompatible nucleating substrate is achieved by contacting such substrate with mantle tissue
explant from a mollusca species under cellular growth promoting conditions. Salt containing media are employed with
variations as to other additives, which may include a source of steroid material, a source of amino acids, a source of
metabolizable energy, or other components. After incubation for sufficient time, nacre coated substrates are formed. By
appropriate choice of the nucleus, pearls can be produced.
Description
METHOD FOR CϋLTϋRING PEARLS
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a continuation-in-part of application serial no. 102,127, filed September 28, 1987.
INTRODUCTION
Technical Field
The subject invention concerns coating of nucleating agents with nacre i_n vitro using mantle tisssue from mollusca.
Background
This invention relates to a methods and compositions of matter utilized therein, for culturing pearls, and in particular to a method of producing pearls by using an in vitro cell culture system to maintain biological and physiochemical activities of the mantle tissues found in pearl forming mollusks and gastropods.
A pearl is a gem most commonly formed by bivalve mollusks, particularly by several marine species known as pearl oysters. Pearls are formed as a protection against the irritation caused by foreign objects, generally parasites, grains of sand, or bits of gravel, which lodge inside the shell. A fold of soft tissue envelopes the foreign particle and deposits layer after layer of nacre on it, similar to the mother-of-pearl lining the shell. Any shelled mollusk or gastropod is theoretically capable of producing a
pearl, but most pearls exhibiting gem quality are produced by a specific genus of pinctada, haliotis, and certain freshwater bivalves.
Techniques for culturing pearls by using live pearl oysters were developed in Japan during the turn of the century. And today, these methods are still employed in which various saltwater and freshwater bivalves are maintained alive during the pearl forming stages. Cultured pearls are generally produced by manually implanting a nucleus with small pieces of mantle tissue in an oyster for approximately two to three years.
Over the years changes in the ecological environment, such as an increase in water pollution and over harvesting of the pearl producing mollusks, have limited the potential productivity of the pearl industries. Furthermore, existing methods of culturing pearls have inherent limitations: 1) Large areas of land and sea must be designated and utilized; Pearl forming oysters must be reared for two to three years before a pearl nucleus can be inserted into the adult oyster; 3) It generally takes another two to three years to produce gem quality pearls themselves; 4) A large work force is needed in pearl producing farms. Consequently, current methods of pearl production have inherent production limitations with resulting limited diversity in the world market and continued high price levels.
SUMMARY OF THE INVENTION
The present invention circumvents the use of live oysters for culturing pearls. It is a process based on a cell culture system specifically designed and developed to provide sustenance and nourishment to pearl forming tissues kept in vitro. The process involves sustaining the viability of mantle tissue explants by providing necessary chemical and physical
components in a culture medium. The composition of the medium to maintain and grow tissues includes a combination of nutrients associated with the naturally available medium in which the tissue grows, which medium may include inorganic salts, a source of amino acids, a sugar source, naturally occurring proteins, etc.
DETAILED DESCRIPTION OF THE INVENTION The mantle tissues found in all shell forming of the phylum Mollusca, including bivalves, and certain gastropods, undergo physiological metabolism to produce intercellular and later to secrete extracellular matrix components responsible for the precipitation of nacreous (mother-of-pearl) material. In the present invention when mantle tissue is extracted from a mollusk and maintained under certain _in vitro conditions, the tissue has physiological characteristics and functions duplicating those in normal biological conditions. The present invention uses complex growth media with the appropriate chemical and physical components necessary to simulate the ideal conditions in vitro for mantle tissues. By employing the media described in this invention the chemical and ultrastructural properties of the pearls produced by this invention are substantially identical to the naturally occurring or cultured pearls currently on the market, as has been demonstrated by a series of electron micrographs comparing the ultrastructure and chemical properties of conventionally cultured pearls with those of the pearls produced by the present invention. From transmission electron micrographs illustrating the surface structure of a conventionally produced cultured pearl presently found on the market and a pearl produced from the present invention, it could be seen that crystal size and shape of the nacre as well as general surface topography are substantially
identical between the two pearls. Chemical identifications using X-ray diffraction of a conventionally produced cultured pearl and a pearl produced by the present invention showed that calcium carbonate (aragonite) is the predominate phase found in both pearls.
COMPLEX GROWTH MEDIUM The culture media used in the process of this invention are complex growth media. The media employed may take many forms, normally providing an environment which to varying degrees approaches the natural fluids, cellular or extracellular. For the most part, the medium will include inorganic salts, a source of amino acids, a source of metabolic energy, normally a metabolizable or assimilable saccharide source, and desirably a source of hormones. For the purposes of the subject disclosure, the various components of the nutrient medium which may be involved may be separated generally into the following components: (i) inorganic salts, (ii) amino acids, (iii) vitamins, (iv) naturally occurring protein containing compositions, (v) antibiotics and antimycotics, (vi) assimilable energy source and (vii) C02, CO3 and/or 02. The nutrient medium will have the inorganic salts necessary for growth of the tissue, approximating the natural medium. In addition, various other factors may be included, where some factors may be provided by the presence of other factors. In some instances, where naturally occurring materials are involved, the naturally occurring material may include the factors which are otherwise added to a synthetic medium. In other instances, the naturally occurring material may serve as an alternative to another component. Therefore, there may be wide variation in the media which are employed, and a number of different media may be employed, each with different degrees of success in
the rapidity with which the pearls are obtained. For example, when using mollusk tissue as a component of the medium, the tissue may serve as a source of amino acids and hormones. Protein hydrolysates may serve as a source of amino acids, so that individual amino acids may not be included. Conditioned medium from the growth of mantle tissue may be employed, where the conditioned medium may be replenished to previous levels of certain components such as an energy source and undesirable factors reduced to a desirable level. The basic medium will have a salt medium approximating the natural medium of the tissue at an appropriate pH, a source of assimilable energy, a source of essential amino acids, and additional factors which promote growth. Such factors may include mollusca tissue, particularly the gonadal tissue components, which may also serve as the source of amino acids, fetal serum, a steriod source such as an androgen extract, yeast extract or the like. The inorganic salts in the growth medium will usually contain all of the ions that are found in the mollusk mantle tissues themselves during their biological activities. In order to determine the chemical nature of the fluid surrounding the mantle tissue, the ionic concentrations of such fluid were investigated and determined. In Table I, the average concentrations of inorganic elements found are shown.
TABLE I Inorσanic Elements
Ion Concentration 1
Ca
Na
K
HC03
Mg
Cl
P
SO.
As a result of the above results, compositions of inorganic salts were formulated for use in the complex growth medium as found in Table II below.
TABLE II Inorganic Salts
Concentration (g/1) Compound Limits Preferred
NaCl KC1
CaCl2
MgCl2*6H20 Na S0
NaH2P04*Ξ20
NaHC03
The salt media proposed above are convenient, but other salt media may be formulated which would provide the desired ionic composition and normalities of the essential ions.
An amino acid analysis was also performed to identify and determine the concentrations of amino acids associated during pearl formation. Although concentrations of the amino acids varies from mollusk to mollusk, the consistency of the amino acid concentrations for a given type of mollusk was noted. The average composition and concentration of amino acids found are shown in Table III below.
Compound
Alanine
Glycine
Aspartic Acid
Leucine
Arginine
Serine
Tyrosine
Phenylalanine
Glutamic Acid
Lysine
Valine
Proline
Isoleucine
Cysteine
Threonine
Methionine
Ξistidine
Cystine
While the mollusk can produce most of the amino acids, in order to enhance growth, it is desirable to provide a supply of those amino acids which enhance the growth of the cells. As a result, certain amino acid components in similar concentrations may be used in the complex growth medium and are shown in Table IV below.
TABLE IV Amino Acids
Concentration (g/1)
Compound Limits Preferred
Glycine
L-alanine
L-arginine
L-asparagine
L-aspartic acid
L-cystine
L-glutamic acid
L-glutamine
L-histidine
L-isoleucine
L-leucine
L-lysine
L-methionine
L-phenylalanine
L-proline
L-serine
L-threonine
L-tryptophan
L-tyrosine
L-valine
Of particular interest as a source of individual amino acids are the amino acids serine, alanine, arginine, aspartic acid, glycine, histidine, leucine, methionine, and phenylalanine. In referring to amino acids, it is understood that the naturally occurring L-stereoisomer is intended. However, instead of individual amino acids, protein hydrolysates or extracts may be employed, by themselves or in conjunction with individual amino acids, where the protein hydrolysates or extracts may provide for a more economical source of amino acids.
Vitamins are optional. If included, the vitamins present in the complex growth medium are similar to those used for other cell and tissue cultures with some variations in concentration. Specific vitamins and concentrations are shown in Table V below. None some or all may actually be used in the complex growth medium.
TABLE V Vitamins
Concentration (mg/1)
Compound Limits Preferred
Biotin
Riboflavin
I-Inositol
Thiamine
Niacin
Choline Chloride
Folic Acid
Ascorbic Acid
Vitamin A (acetate)
Pyridoxine
The hormones found associated at or near the activities of the mantle tissues were determined and may be classified as corticosteroids, androgens or modified versions of estrogen. These hormonal components or metabolic intermediates were added to the medium to facilitate biosynthesis of these hormones. Androgen extract may be obtained from commercial sources and may be used in amounts varying from 0.005 to 0.2 mg/L. It has been observed that a growth medium containing serum extracts from the reproductive organs of the same mollusk was observed to yield the most success in proliferating the growth of the mantle tissues. The serum extracts were found to provide the levels of hormones necessary to sustain mantle tissue growth. Without the presence of this reproductive organ serum, however, the hormone additives, although not essential in maintaining tissue culture, were found to be desirable in enhancing tissue growth.
Of particular interest is to use tissue from the mantle explant source or other related species, particularly comprising gonadal tissue or lyophilized gonadal tissue. The tissue may be minced or ground either before or after lyophilization to provide the tissue in easily dispersible form, e.g. a powder. The tissue when employed will be composed of cells, fragments of the cells and other materials present in the tissue when removed from the source. The "lyophilized tissue may be dispersed in the nutrient medium under mild conditions with agitation, and may be incorporated in biocompatible gels, such as agar or collagen gels. The amount of the lyophilized tissue may be varied widely and may be optimized in accordance with the other components of the nutrient medium. Beneficial results may be obtained by using a ratio of from about 0.1 to 2 of the volume of the tissue prior to lyophilization to the volume of medium.
Antibiotics and anti ycotics such as
penicillin and streptomycin may also be used during tissue extraction procedures and may also be used to control contamination levels during mantle tissue culture. The antibiotics and antimycotics used in the complex growth medium are listed below in Table VI.
TABLE VI Antibiotics and Antimycotics
Compound Concentration
Streptomycin 50 - 200 yg/ml
Penicillin G, Sodium 100 - 2,000 U/ml
Although growth and maintenance of the mantle tissues were successful without the addition of a source of energy, at least one saccharide was added to the growth medium to provide an additional source of energy to the cells. Saccharide sources include glucose, galactose, glycogen, sucrose, etc.
Other components which were employed in one or more formulated growth media are listed in Table VII below. The lactalbumin hydrolysate provided significant benefits in the absence of other protein sources.
TABLE VII Other Components
Concentration
Com ound Limits Preferred
The system is buffered to provide a physiologically acceptable pH. Sodium bicarbonate (inorganic salt) and phenol red were added to control and monitor the pH of the solution. The preferred pH range is 7.2 to 7.9. However, a pH as low as 6.5 and as high as 9.3 have been observed to sustain viability of the mantle tissues. Carbon dioxide enriched air or a carbonated source was added to the growth medium to keep the pH of the medium within the overall range of 6.6 to 8.9.
Commercially available cell culture media, e.g., Gibco, Inc., New York, were modified and tested for culturing mantle tissues. The modifications made were generally: (i) addition of sodium bicarbonate and glucose, (ii) adition of appropriate concentrations of NaCl to obtain the correct osmolality in the solutions, and (iii) 1 M NaOH solutions were often added to bring the pH in the solution to 7.4 or above.
Various complex growth media compositions were used successfully in- producing pearls. Specific
examples are listed below in Tables VIIIA, VIIIB, and VIIIC.
TABLE VIIIA Complex Growth Medium "A"
Com ound Concentration
TABLE VIIIB Complex Growth Medium "B"
Compound Concentration
Inorganic Salts:
NaCl
KC1
Na2HP04'H20
CaCl2
NaΞC03
Amino Acids:
Serine
Alanine
Arginine
Aspartic Acid
Glycine
Histidine
Leucine
Methionine
Phenylalanine
Other Components:
Glucose
Fetal Calf Serum
Biofin
Niacin
Ascorbic Acid
Vitamin A (acetate)
Penicillin
Streptomycine
Phenol Red
TABLE VIIIC Complex Growth Medium "C"
Compound Concntration
Modified version of commercially available medium, i.e.. Medium 199: Gibco Laboratories, Inc., Grand Island, NY. Plus following additives:
Yeast Extraction 10 g/1
(Yeastolate: Gibco Lab)
Penicillin 100 U/ml
Phenol Red 5 mg/ml
Formulations were prepared for growth media using distilled water containing the salt composition of Medium A or sea water and gonad organ extracts, where the gonad organ extracts were obtained by isolating the gonads from the body mass of the mollusc, lyophilizing the gonadal tissue and grinding the tissue to form a powder. The powder was then uniformly dispersed in the water by stirring. The amount of gonadal tissue was based on the original volume of the tissue and was in a volume ratio to water of 0.25 to 1. Other formulations combined the above formulation or used androgen extract (Sigma) in place of the gonadal tissue. The androgen extract ranged in the amount of 0.01 to O.lmg/L.
Invention Process
A portion or all of a mantle tissue is explanted from a mollusk or gastropod which belong to genus thereof which produce mother-of-pearl material in their shells, such as the genera Pinctada, Isognomon, Pteria, Pinna, Haliotis, Atrima, etc., e.g., Pinctada martensii, Pinctada margritifera, Pinctada maxima, Pinctada fucata, Pteria macroptera, Atrima japonica, Ostrea gigas, Unio margritifera, Cristaria plicata, Tridacna gigas, Haliotis gigantea, Ξypriopsis schlegeli, Haliotis fulgens, Haliotis corrugata, Haliotis cracherodii, Haliotis discus hannai, Ligumia nasuta, Elliptio complanata, Strophitus undulatus, Anodonta caturacta, and Lamsilis radiata, for the purpose of in vitro cultivation so as to produce nacreous material for pearl formation.
The pieces of the mantle tissue fragments are optionally washed in seawater containing antibiotics and/or antimycotics, e.g., 100 Units penicillin G (sodium salt)/ml and 100 ug/ml streptomycin. The seawater may be prepared in the laboratory and would consist generally of water with inorganic salts in
concentrations thereof as indicated in Table II above. The tissue part(s) or intact mantle tissue(s) are transferred into a carbon dioxide or oxygen enriched complex growth medium comprised of inorganic salts, amino acids, vitamins and growth factors, hormones, antibiotics and antimycotics, animal serum extracts and glucose.
Biocompatible material such as glass, porcelain, old shells containing calcite and/or the aragonite phase(s) of calcium carbonate, and/or calcium phosphates in the form of spheres or hemispheres are introduced into the medium for nacre deposition. The material which serves as a nucleating substrate may be of any shape, normally being round or ellipsoid for pearl formation. Usually, the smallest dimension of the material which serves as the substrate will be usually at least about 1mm, usually at least about 2mm and may be as large as 20mm or larger. For pearls, the substrate will usually have a diameter from about 2 to 15, usually 7 to 10mm.
In one successful embodiment of the invention process, small, i.e., less than 1 mπr pieces of mantle tissue were sectioned and removed from a pearl forming adult mollusk. Each piece was washed in saltwater containing the inorganic salt components described above and placed in pre-sterilized culture dishes. Sterilized complex growth medium, filtered through a 0.22 μm millipore filter (Millipore Corp., Bedford, MA 01730) was immediately added to each dish containing the tissue fragments. Small nuclei, i.e., glass beads or spheres made from clam shells, were then placed in each dish and positioned so that maximal physical contact was made with the tissue. The cultures were maintained between 14°C and 23°C in the dark by incubation means. However, experimentation has shown that the invention process will withstand temperatures ranging from 8°C to 29°C. Carbon dioxide enriched air
was introduced and withdrawn in sufficient quantities to effectively keep the pH of the medium in a range from 6.6 to 8.9. The medium was replenished using syringes when the pH indicating phenol red changed colors. The bright phenol red changes to a bluish red as the pH rises from 7.4 to 8. The bright phenol red changes shade toward pink or yellow as the pH drops from 7.4 to 6.5. The pH of this medium tended, however, to rise. The removal of old medium and substitution of fresh medium took place every one to three days and continued until production of a pearl of desired quality and size was achieved. Optionally, the medium is changed every two days or when the medium pH rises above 7.8, whichever occurs sooner and depending on tissue mass to medium content ratio. Precise measurement of pH may be done with a pH measuring apparatus. After the pearl reached its desired quality and/or size, it was removed from the dish and the attached tissue removed. The removed tissue was dissected and fragments thereof used again in the production of additional pearls.
It is understood that the above described embodiment is merely illustrative of the application. Other embodiments, therefore, may be readily devised by those skilled in the art which will embody the principles of the invention and fall within the spirit and scope thereof. The appended claims are intended to cover such modifications and variations which are within the true scope and spirit of this invention. All publications and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Although the foregoing invention has been de¬ scribed in some detail by way of illustration and ex¬ ample for purposes of clarity of understanding, it will
be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
Claims
1. A method for coating a biocompatible nucleus with nacre in an ^n vitro culture medium, said method comprising:
contacting a biocompatible nucleus with live mantle tissue of nacre producing members of the phylum mollusca in an appropriate nutrient medium; incubating said tissue under growth supporting conditions for sufficient time for said tissue to coat said nucleus with nacre; and isolating the resulting nacre coated nucleus.
2. A method according to Claim 1, wherein said medium comprises at least one of mollusca blood, mollusca gonadal components, a source of steriod, yeast extract or fetal serum.
3. A method according to Claim 1, wherein said medium comprises a source of assimilable sugars and/or amino acids.
4. A method according to any one of Claims 1 to 3, wherein said medium has a salt composition simulating the salt composition of the natural medium of said mollusca.
5. A method for coating a biocompatible nucleus with nacre in a culture medium, said method comprising:
contacting a biocompatible nucleus with live mantle tissue of a nacre producing mollusc or gastropod in an appropriate nutrient medium, said medium comprising salts simulating the natural medium of said mollusc or gastropod, a source of amino acids and/or an assimilable saccharide source incubating said tissue under growth supporting conditions for sufficient time for said tissue to coat said nucleus with nacre; and isolating the resulting nacre coated nucleus.
6.. A method according to Claim 5, wherein said nucleus is comprised of calcium carbonate.
7. A method according to any of Claims 1 to 6, wherein said nutrient'medium further comprises at least one of mollusca blood, mollusca gonadal components, a source of steroid or fetal serum.
8. A method according to any of Claims 1 to 7, wherein said mollusca is Pinctada martensii, Pinctada margritifera, Pinctada maxima, Pinctada fucate, Pteria macroptera, Atrima japonica, Ostrea gigas, Unio margritifera, Cristaria plicata, Tridacna gigas, Haliotis gigantea, Hypriopsis schlegeli, Haliotis fulgens, Haliotis corrugata, Haliotis cracherodii, Haliotis discus hannai, Ligumia nasuta, Elliptio complanata, Strophitus undulatus, Anodonta caturacta, or Lamsilis radiata.
9. A nacre coated nucleus produced according to the method of any of Claims 1 to 8.
10. A nutrient medium for coating a biocompatible nucleus with nacre using mantle tissue said medium comprising:
a salt solution comprising salts simulating the natural medium associated with said mantle tissue; optionally, a source of amino acids; a source of assimilable saccharide; at least one of mollusca blood, mollusca gonadal components, a source of steriod, yeast extract or fetal serum.
11.. A nutrient medium according to Claim 10, wherein said source of amino acids includes at least one individual amino acid, said assimilable saccharide comprises at least one. of glucose or galactose, and further comprises mollusca gonadal components.
12. A nutrient medium according to Claim 10, wherein said source of amino acids includes at least one individual amino acid, said assimilable saccharide comprises at least one of glucose or galactose, and further comprises a source of steriod.
13. A composition comprising live mantle tissue from a nacre producing mollusca, a biocompatible nucleus and a nutrient medium according to any of Claims 10 to 12.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10212787A | 1987-09-28 | 1987-09-28 | |
| US102127 | 1987-09-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0335955A1 true EP0335955A1 (en) | 1989-10-11 |
| EP0335955A4 EP0335955A4 (en) | 1990-05-14 |
Family
ID=22288251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19880909428 Ceased EP0335955A4 (en) | 1987-09-28 | 1988-09-27 | Method for culturing pearls. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0335955A4 (en) |
| JP (1) | JPH02501441A (en) |
| KR (1) | KR890701006A (en) |
| AU (1) | AU611508B2 (en) |
| CA (1) | CA1321964C (en) |
| WO (1) | WO1989002919A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2682965A1 (en) * | 1991-10-23 | 1993-04-30 | Camprasse Georges | PRODUCTION OF BONE AND PEARL FROM CULTURE OF BONE FORMING CELLS. |
| FR2684686B1 (en) * | 1991-12-06 | 1994-12-23 | Bertin & Cie | CULTURE MEDIA FOR MARINE INVERTEBRATE CELLS. |
| US7062940B2 (en) | 2002-12-13 | 2006-06-20 | Chi Huynh | Carved pearl |
| JP2010509933A (en) * | 2006-11-22 | 2010-04-02 | インディアン カウンシル オブ アグリカルチュラル リサーチ | In-vitro pearl production method using marine organisms |
| CN110637763B (en) * | 2019-09-26 | 2021-05-04 | 中国科学院南海海洋研究所 | A kind of preparation method of Tridacna shell shape and mantle color characters interchangeable |
| CN110684709B (en) * | 2019-10-21 | 2021-01-22 | 福建罗屿岛食品有限公司 | A kind of disc abalone cell culture medium and construction method of cell line |
| CN112919943A (en) * | 2021-03-26 | 2021-06-08 | 生态环境部华南环境科学研究所 | Composting agent for efficiently removing steroid estrogen in livestock and poultry manure and aerobic composting method |
-
1988
- 1988-09-27 KR KR1019890700947A patent/KR890701006A/en not_active Withdrawn
- 1988-09-27 JP JP63508678A patent/JPH02501441A/en active Pending
- 1988-09-27 CA CA000578599A patent/CA1321964C/en not_active Expired - Fee Related
- 1988-09-27 EP EP19880909428 patent/EP0335955A4/en not_active Ceased
- 1988-09-27 AU AU26081/88A patent/AU611508B2/en not_active Ceased
- 1988-09-27 WO PCT/US1988/003325 patent/WO1989002919A1/en not_active Ceased
Non-Patent Citations (3)
| Title |
|---|
| BULLETIN OF THE JAPANESE SOCIETY OF SCIENTIFIC FISHERIES, vol. 41, no. 10, 1975, page 1083; I. YANO et al.: "Amino acid composition of dark brown secretion formed on organ culture of mantle tissue of the pearl oyster" * |
| J. MALACOL. SOC. AUSTRAL., vol. 2, no. 4, 1973; T. G. DIX et al. : "Histology of the mantle and pearl sac of the pearl oyster pinctada maxima (lamellibranchia)" * |
| See also references of WO8902919A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1321964C (en) | 1993-09-07 |
| AU611508B2 (en) | 1991-06-13 |
| JPH02501441A (en) | 1990-05-24 |
| WO1989002919A1 (en) | 1989-04-06 |
| AU2608188A (en) | 1989-04-18 |
| KR890701006A (en) | 1989-12-19 |
| EP0335955A4 (en) | 1990-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ebner et al. | Cultivation and properties of bovine mammary cell cultures | |
| Biesiot et al. | Changes in digestive enzyme activities during early development of the American lobster Homarus americanus Milne Edwards | |
| Rivkin et al. | Bacterivory: a novel feeding mode for asteroid larvae | |
| Ambesi-Impiombato et al. | Thyroid cells in culture | |
| AU724447B2 (en) | Medium composition for external fertilization | |
| Vago | Invertebrate tissue culture | |
| Cheng et al. | Aquaculture of the tropical sea cucumber, Stichopus monotuberculatus: Induced spawning, detailed records of gonadal and embryonic development, and improvements in larval breeding by digestive enzyme supply in diet | |
| CN101491228A (en) | Sea no-nucleus pearl incubation method | |
| Desrosiers et al. | Early developmental events following fertilization in the giant scallop () Placopecten magellanicus | |
| KR20060076781A (en) | Cell culture medium | |
| Gong et al. | Characterization of calcium deposition and shell matrix protein secretion in primary mantle tissue culture from the marine pearl oyster Pinctada fucata | |
| Fraser et al. | Studies on primary cell cultures derived from ovarian tissue of Penaeus monodon | |
| CA1321964C (en) | Method for culturing pearls | |
| Sud et al. | Role of water-soluble matrix fraction, extracted from the nacre of Pinctada maxima, in the regulation of cell activity in abalone mantle cell culture (Haliotis tuberculata) | |
| Wyss | Ecdysterone, insulin and fly extract needed for the proliferation of normal Drosophila cells in defined medium | |
| Xing et al. | The potential value of different species of benthic diatoms as food for newly metamorphosed sea urchin Strongylocentrotus intermedius | |
| Mitsuhashi | Development of highly nutritive culture media | |
| Mercurio et al. | Primary cell cultures from sea urchin ovaries: a new experimental tool | |
| US4449480A (en) | Culture of freshwater mussel glochidia in an artificial habitat utilizing complex liquid growth media | |
| CN118370247B (en) | Method for improving survival rate of hong Kong giant oyster under high-salt condition | |
| Le Marrec-Croq et al. | Primary cultures of heart cells from the scallp Pecten maximus (mollusca-bivalvia) | |
| CN108265021B (en) | Leech cell in-vitro culture medium and culture method thereof | |
| CN109022346B (en) | Marine invertebrate cell culture medium | |
| Kirk et al. | Morphologically stable epithelial vesicles cultured from normal human endometrium in defined media | |
| Ferkovich et al. | Rearing of ectoparasitoid Diapetimorpha introita on an artificial diet: supplementation with insect cell line-derived factors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19890619 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19900514 |
|
| 17Q | First examination report despatched |
Effective date: 19920722 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
| 18R | Application refused |
Effective date: 19940106 |